Server:cloudflare...
The main IP address: 217.114.92.80,Your server Sweden,Stockholm ISP:EPiServer AB TLD:uk CountryCode:SE
The description :navigation content footer uk novartis site directory search our work clinical trials disease areas novartis in the uk about us the novartis group who we are corporate responsibility our commitment to...
This report updates in 09-Dec-2018
Created Date: | 2014-10-24 |
Changed Date: | 2016-09-23 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host entresto.co.uk. Currently, hosted in Sweden and its service provider is EPiServer AB .
Latitude: | 59.332580566406 |
Longitude: | 18.06489944458 |
Country: | Sweden (SE) |
City: | Stockholm |
Region: | Stockholms Lan |
ISP: | EPiServer AB |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.
Expect-CT: | max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" |
X-Drupal-Cache: | MISS |
Transfer-Encoding: | chunked |
CF-Cache-Status: | HIT |
Last-Modified: | Sun, 09 Dec 2018 03:35:27 GMT |
X-Frame-Options: | SAMEORIGIN |
X-Request-ID: | 56a120edb6e96611d4cee6936f56de1f |
Content-Language: | en |
Expires: | Sun, 09 Dec 2018 11:45:23 GMT |
Link: | |
Date: | Sun, 09 Dec 2018 05:45:23 GMT |
CF-RAY: | 48652a4fda2621fe-EWR |
X-AH-Environment: | prod |
Set-Cookie: | __cfduid=d1a29bee15645cb94e7698d3a77b5f6121544334323; expires=Mon, 09-Dec-19 05:45:23 GMT; path=/; domain=.novartis.co.uk; HttpOnly |
Server: | cloudflare |
Connection: | keep-alive |
X-Acquia-Application-UUID: | bd001528-a8b3-27d4-29e1-34e36bb6ed42 |
X-Content-Type-Options: | nosniff |
Content-Encoding: | gzip |
X-UA-Compatible: | IE=edge,chrome=1 |
X-Acquia-Application-Trace: | XAyNfwpkJKQAAGpr@-sAAAAI |
Cache-Control: | public, max-age=21600 |
Content-Type: | text/html; charset=utf-8 |
soa: | dns1.novartis.com. hostmaster.novartis.com. 2018092001 86400 3600 2592000 172800 |
ns: | dns2.novartis.com. mia03-1.digex.com. dns1.novartis.com. |
ipv4: | IP:217.114.92.80 ASN:30811 OWNER:EPISERVER_AS, SE Country:SE |
navigation content footer uk novartis site directory search our work clinical trials disease areas novartis in the uk about us the novartis group who we are corporate responsibility our commitment to patients and caregivers contact us partnerships with the nhs with patient groups patient resources grants and sponsorships access to healthcare news uk news and media releases media library annual report novartis world news press office careers career search working at novartis future talent programme graduate recruitment homepage at novartis, we are reimagining medicine the extraordinary need for an ordinary life novartisuk colleagues share their personal healthcare challenges in a new campaign #novartisiswithyou read the story nhs70 reflections from our managing director and country president, haseeb ahmad read the story collaborates with buckinghamshire healthcare nhs trust to improve patients’ experience read about the collaboration between and buckinghamshire healthcare nhs trust... read more community partnership day 2018 our community partnership day is a very special day in the novartis calendar. read more , a top employer 2018 hear from erica cassin, hr director at , on what winning uk and europe top employer... read more navigate novartis the novartis group uk news and media releases careers partnerships media releases novartis announces new data that shows entresto™▼(sacubitril/valsartan) can be initiated both pre- or post-discharge with comparable safety and tolerability in patients with heart failure novartis announces eu approval of gilenya® (fingolimod), the first licensed oral treatment for paediatric ms novartis to move uk headquarters to london in bold move to join emerging life sciences cluster novartis receives european licence for luxturna®▼ (voretigene neparvovec), the first one-time gene therapy to improve visual acuity in people with rare inherited retinal disease read more @novartisuk 1 day 17 hours ago rt @abpi_uk: exercising is good for preventing migraine, but getting the balance right is tricky. jane's hope is to have the cha… https://t.co/md4qllqyeq follow us who we are novartis develops, manufactures and markets innovative medicines, devices and diagnostic tests which help improve patient outcomes. learn more corporate brochure find out more about our large and diverse organisation in our corporate brochure learn more our work about us partnerships news careers locations contact us modern slavery statement subscribe to novartis facebook twitter linkedin novartis site directory © 2018 novartis ag this site is intended for an audience in the united kingdom terms of use privacy policy about cookies accessibility modern slavery statement
https://www.novartis.co.uk/news/uk-news-and-media-releases?type=all
https://www.novartis.co.uk/news/media-releases/novartis-move-uk-headquarters-london-bold-move-join-emerging-life-sciences
https://www.novartis.co.uk/stories/hope/extraordinary-need-ordinary-life
https://www.novartis.co.uk/stories/global-impact/novartis-uk-celebrates-22nd-community-partnership-day-2018
https://www.novartis.co.uk/our-work/novartis-uk
https://www.novartis.co.uk/about-us
https://www.novartis.co.uk/partnerships/patient-resources
https://www.novartis.co.uk/our-work/clinical-trials
https://www.novartis.co.uk/stories/hope/novartis-uk-collaborates-buckinghamshire-healthcare-nhs-trust-improve-patients
https://www.novartis.co.uk/about-us/contact-us
https://www.novartis.co.uk/about-us/contact-us/novartis-site-directory
https://www.novartis.co.uk/#footer
https://www.novartis.co.uk/#
https://www.novartis.co.uk/privacy-policy
https://www.novartis.co.uk/careers
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain name:
entresto.co.uk
Registrant:
Novartis AG
Registrant type:
Other UK Entity (e.g. clubs, associations, many universities)
Registrant's address:
P.O. Box CH-4002
Basel
CH
4002
Switzerland
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 27-May-2014
Registrar:
Markmonitor Inc. t/a MarkMonitor Inc. [Tag = MARKMONITOR]
URL: http://www.markmonitor.com
Relevant dates:
Registered on: 24-Oct-2014
Expiry date: 24-Oct-2018
Last updated: 23-Sep-2016
Registration status:
Registered until expiry date.
Name servers:
dns1.novartis.com
dns2.novartis.com
mia03-1.digex.com
WHOIS lookup made at 06:40:36 26-Jan-2018
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS entresto.co.uk
PORT 43
TYPE domain
OWNER
ORGANIZATION Novartis AG
TYPE
Other UK Entity (e.g. clubs, associations, many universities)
ADDRESS
P.O. Box CH-4002
Basel
CH
4002
Switzerland
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 27-May-2014
DOMAIN
SPONSOR Markmonitor Inc. t/a MarkMonitor Inc. [Tag = MARKMONITOR]
CREATED 2014-10-24
CHANGED 2016-09-23
STATUS
Registered until expiry date.
NSERVER
DNS1.NOVARTIS.COM 160.62.4.7
DNS2.NOVARTIS.COM 160.62.7.59
MIA03-1.DIGEX.COM 164.109.2.40
NAME entresto.co.uk
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .